DrugPatentWatch Database Preview
Nexus Pharms Company Profile
Email this page to a colleague
» See Plans and PricingWhat is the competitive landscape for NEXUS PHARMS, and what generic and branded alternatives to NEXUS PHARMS drugs are available?
NEXUS PHARMS has nine approved drugs.
Summary for Nexus Pharms
| US Patents: | 0 |
| Tradenames: | 9 |
| Ingredients: | 9 |
| NDAs: | 9 |
Drugs and US Patents for Nexus Pharms
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nexus Pharms | PROCAINAMIDE HYDROCHLORIDE | procainamide hydrochloride | INJECTABLE;INJECTION | 206332-002 | Oct 13, 2017 | AP | RX | No | No | Start Trial | Start Trial | ||||
| Nexus Pharms | PROCAINAMIDE HYDROCHLORIDE | procainamide hydrochloride | INJECTABLE;INJECTION | 206332-001 | Oct 13, 2017 | AP | RX | No | No | Start Trial | Start Trial | ||||
| Nexus Pharms | PROCHLORPERAZINE EDISYLATE | prochlorperazine edisylate | INJECTABLE;INJECTION | 204860-001 | Feb 15, 2019 | AP | RX | No | No | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
